...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening
【24h】

Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening

机译:通过高通量筛选发现新型TAOK2抑制剂支架

获取原文
获取原文并翻译 | 示例
           

摘要

The MAP3K (Mitogen Activated Protein Kinase Kinase Kinase) TAOK2 (Thousand-And-One Kinase 2) is an activator of p38 MAP kinase cascade that is up-regulated in response to environmental stresses. A synthetic lethal screen performed using a NSCLC (non-small cell lung cancer) cell line, and a second screen identifying potential modulators of autophagy have implicated TAOK2 as a potential cancer therapeutic target. Using a 200,000 compound high throughput screen, we identified three specific small molecule compounds that inhibit the kinase activity of TAOK2. These compounds also showed inhibition of autophagy. Based on SAR (structure-activity relationship) studies, we have predicted the modifications on the reactive groups for the three compounds. (C) 2016 Elsevier Ltd. All rights reserved.
机译:MAP3K(促分裂原活化蛋白激酶激酶激酶)TAOK2(一千个激酶2)是p38 MAP激酶级联反应的活化剂,可响应环境压力而被上调。使用NSCLC(非小细胞肺癌)细胞系进行的合成致死筛选和确定自噬潜在调节剂的第二次筛选已暗示TAOK2作为潜在的癌症治疗靶标。使用200,000种化合物的高通量筛选,我们鉴定了三种抑制TAOK2激酶活性的特定小分子化合物。这些化合物也显示出对自噬的抑制作用。基于SAR(结构-活性关系)研究,我们预测了这三种化合物的反应性基团的修饰。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号